Health Invest Partners Ab Rigel Pharmaceuticals Inc Transaction History

Health Invest Partners Ab

  • $206 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 05, 2022
SELL
$2.22 - $3.45 $2.42 Million - $3.76 Million
-1,090,000 Closed
0 $0
Q4 2021

Jan 18, 2022
SELL
$2.36 - $3.57 $1.59 Million - $2.41 Million
-675,000 Reduced 38.24%
1,090,000 $2.89 Million
Q3 2021

Nov 08, 2021
BUY
$3.5 - $4.5 $6.18 Million - $7.94 Million
1,765,000 New
1,765,000 $6.41 Million

Others Institutions Holding RIGL

# of Institutions
8
Shares Held
334K
Call Options Held
0
Put Options Held
0
View Full List

About RIGEL PHARMACEUTICALS INC

RIGL Quotes by TradingView
  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $4.5B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Health Invest Partners Ab Portfolio

Follow Health Invest Partners Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Invest Partners Ab, based on Form 13F filings with the SEC.

News

Stay updated on Health Invest Partners Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email